Related Experiment Video
Updated: May 27, 2026
In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex
Anja Kastl1, Alexander Wilbuer, Anna Lena Merkel
1Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Strasse, 35043 Marburg, Germany.
Abstract:
A metal complex is identified in which the metal fulfills two independent functions: as a structural scaffold for the specific molecular recognition of protein kinases resulting in antiangiogenic properties, together with a visible-light-induced photoreactivity triggering apopotosis in cancer cells.
Insights
A novel metal complex acts as a scaffold for protein kinase recognition, inhibiting tumor growth. It also uses visible light to trigger cancer cell death via apoptosis.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Materials Science
Background:
- Targeting protein kinases is crucial for cancer therapy.
- Developing agents with dual functionality (targeting and photoactivation) is a key challenge.
Purpose of the Study:
- To identify a metal complex with dual anti-cancer functions.
- To explore its potential as an antiangiogenic and photodynamic therapeutic agent.
Main Methods:
- Synthesis and characterization of a novel metal complex.
- In vitro assays for protein kinase binding and antiangiogenic activity.
- Evaluation of visible-light-induced apoptosis in cancer cells.
Main Results:
- The metal complex demonstrated specific molecular recognition of protein kinases.
- Significant antiangiogenic properties were observed.
- Visible-light irradiation effectively triggered apoptosis in cancer cells.
Conclusions:
- The identified metal complex possesses dual therapeutic potential.
- It serves as a structural scaffold and a photoactive agent for cancer treatment.
